M&A Deal Summary |
|
---|---|
Date | 2011-02-01 |
Target | Archimica |
Sector | Life Science |
Buyer(s) | Archimica |
Sellers(s) |
TowerBrook Capital Partners
Aisling Capital |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Archimica offers small- to large-scale commercial manufacturing as well as analytical support for the global biopharmaceutical market. The company is specialized in custom synthesis and the manufacture of active pharmaceutical ingredients (“APIs”). Archimica was founded in 1946 and is based in Lodi, Italy.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Virginia) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2011) | 1 of 1 |
Category | Private Equity Firm |
---|---|
Founded | 2001 |
PE ASSETS | 17.4B USD |
Size | Mega |
Type | Sector Agnostic |
TowerBrook Capital Partners is a private equity firm focused on leveraged buyouts, leveraged build-ups and distressed situation investments throughout North America and Europe. TowerBrook prefers control-oriented investments and actively pursues complex situations that other firms may avoid. Target sectors include consumer services, distribution, beverages, pharmaceuticals, media, technology, communications, software, and healthcare. TowerBrook Capital Partners was established in 2001 and is headquartered in New York City.
DEAL STATS | # |
---|---|
Overall | 14 of 46 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 6 of 21 |
State (Virginia) | 1 of 1 |
Country (United States) | 10 of 24 |
Year (2011) | 2 of 5 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-01-04 |
DISA
Houston, Texas, United States DISA specializes in providing a comprehensive suite of employee testing, screening, and compliance management solutions to a diverse set of end markets. DISA was founded in 1986 and is based in Houston, Texas. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-02-17 |
Phase Eight
LONDON, United Kingdom Phase Eight offers a range of evening wear, bridalwear and accessories aimed at the 35- to 55-year-old woman. It has 107 stores and 203 concessions throughout the U.K. and Ireland as well as 15 stores and 113 concessions in 16 international markets including Europe, the Middle East and Asia. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 2000 |
PE ASSETS | 1.8B USD |
Size | Large |
Type | Sector Focused |
Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.
DEAL STATS | # |
---|---|
Overall | 15 of 41 |
Sector (Life Science) | 13 of 32 |
Type (Add-on Acquisition) | 14 of 24 |
State (Virginia) | 1 of 1 |
Country (United States) | 15 of 41 |
Year (2011) | 1 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-05-28 |
Aton Pharma
Lawrenceville, New Jersey, United States Aton Pharma, Inc. is a specialty pharmaceutical company providing unique medicines to patients around the world.With 11 products on the market, 8 in the pipeline, and sales in over 30 countries, we are a global leader in providing medically essential treatments for serious and potentially life-threatening medical conditions. Our products address 2 areas — ophthalmic and orphan drug (rare disease) markets. |
Sell | $318M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-07-01 |
Miramar Labs
Sunnyvale, California, United States Miramar Labs is a privately owned medical device company dedicated to launching the next generation energy modality to treat dermatologic medical conditions. Miramar Labs was founded in 2006 and is based in Sunnyvale, California. |
Buy | - |